- Home
- GNTA vs NNOX Comparison
GNTA vs NNOX Comparison
Compare GNTA & NNOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GNTA | NNOX |
|---|---|---|
| Founded | 2014 | 2011 |
| Country | Italy | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medical Electronics |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 62.7M | 69.6M |
| IPO Year | 2021 | 2019 |
Fundamental Metrics
Financial Performance| Metric | GNTA | NNOX |
|---|---|---|
| Price | $0.99 | $0.95 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $5.00 |
| AVG Volume (30 Days) | 33.0K | ★ 1.3M |
| Earning Date | 03-24-2026 | 04-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $147.55 |
| Revenue Next Year | N/A | $81.13 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.55 | $0.72 |
| 52 Week High | $10.00 | $4.71 |
Technical Indicators
Market Signals| Indicator | GNTA | NNOX |
|---|---|---|
| Relative Strength Index (RSI) | 34.71 | 48.16 |
| Support Level | $0.58 | $0.85 |
| Resistance Level | $1.70 | $1.16 |
| Average True Range (ATR) | 0.07 | 0.07 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 15.68 | 75.35 |
Price Performance
Historical ComparisonAbout GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon, a product to treat glioblastoma multiforme, a solid tumor affecting the brain.
About NNOX NANO-X IMAGING LTD
Nano X Imaging Ltd is focused on driving the world's transition to preventive health care by delivering an integrated, end-to-end medical imaging and healthcare services platform. The group combines affordable imaging hardware, progressive AI-based solutions, cloud-based software, access to remote radiology, health IT solutions, and a marketplace to enable earlier detection, improved clinical efficiency, and broader access to care. The three segments are composed of the Nanox.ARC segment, the AI and software solutions segment, and the Radiology services segment. Key revenue is generated from Radiology Services.